Spark Therapeutics, Inc (ONCE) Covered Calls
Spark Therapeutics Inc is a gene therapy company. The Company is engaged in developing one-time, life-altering gene therapy treatments to transform the lives of patients and re-imagine the treatment of debilitating diseases.
You can sell covered calls on Spark Therapeutics, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ONCE (prices last updated Tue 4:16 PM ET):
| Spark Therapeutics, Inc (ONCE) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 40.80 | -0.66 | 38.00 | 42.45 | 387K | - | 0.0B |
| Covered Calls For Spark Therapeutics, Inc (ONCE) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| Dec 21 | 40 | 2.00 | 40.45 | -1.1% | -36.5% | |
| Jan 18 | 40 | 3.20 | 39.25 | 1.9% | 17.8% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
Spark Therapeutics, Inc. engages in gene therapy research, development, manufacturing and clinical trials. The company is developing one-time, life-altering gene therapy treatments to transform the lives of patients and re-imagine the treatment of debilitating diseases. Its initial focus is on treating orphan diseases, and it has demonstrated promising clinical outcomes with its first product candidate targeting rare blinding conditions, which has received both breakthrough therapy and orphan product designation and is in a fully enrolled, pivotal Phase 3 clinical trial. The company also has built a pipeline of product candidates targeting additional blinding conditions, hematologic disorders and neurodegenerative diseases, including a second product candidate targeting another rare blinding condition. Spark Therapeutics was founded by Jeffrey D. Marrazzo, Katherine A. High and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA.
| Top 10 Open Interest For Dec 21 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | DUST covered calls | 6. | NSSC covered calls | 1. | covered calls | |
| 2. | NOVT covered calls | 7. | MOD covered calls | 2. | covered calls | |
| 3. | MMS covered calls | 8. | VV covered calls | 3. | covered calls | |
| 4. | VSI covered calls | 9. | EC covered calls | 4. | covered calls | |
| 5. | DXJS covered calls | 10. | NTWK covered calls | 5. | covered calls | |
Want more examples? ONB Covered Calls | ONDK Covered Calls
